News

Bronchiectasis is one of the most neglected chronic lung diseases despite the fact it impacts 300,000 people in the UK ...
Apogee Therapeutics Inc. (NASDAQ:APGE) is one of the best hot stocks to buy according to Wall Street analysts. Earlier in May ...
Urban pollution has emerged as one of the most critical environmental and public health challenges in Khyber Pakhtunkhwa (KP) ...
The global Therapeutic Respiratory Devices Market is estimated to be valued at USD 55.40 billion in 2025 and is projected to reach USD 86.03 billion by 2035, registering a compound annual growth rate ...
Researchers have found in a new study over a 15-year follow-up that adults with asthma showed significantly higher rates of ...
Dr Anna Moore and Catherine Furlong explain how singing can improve lung health for people with chronic respiratory disease ...
Fireworks are happening across the city again this year, which poses two issues–highly concentrated pollution, and uniquely ...
The Business Research Company's Asthma and COPD Drugs Market 2025: Strategic Insights for Growth, Expansion, and Gaining Competitive Edge It will grow to $50.99 billion in 2029 at a compound annual ...
The report provides a detailed analysis of the current dyspnea marketed drugs and late-stage pipeline drugs. BROOKLYN, NY, ...
Depemokimab significantly reduces asthma exacerbations, benefiting patients regardless of their baseline asthma control levels. A biologics license application for depemokimab is currently being ...
Digital inhalers may help predict occurrence of acute exacerbations of COPD for patients in an ambulatory setting.
Research shows that digital inhalers equipped with remote monitoring capabilities may aid in predicting and identifying ...